Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00201149 · ClinicalTrials.gov registry record · NA

Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence

A NA study of Hypertension and Cardiovascular Diseases, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
870
Enrollment target
1
Study location

NCT00201149: Completed NA study of Hypertension and Cardiovascular Diseases, sponsored by Boston Medical Center.

NCT00201149 is a NA study of Hypertension and Cardiovascular Diseases that has completed, run by Boston Medical Center. The registered enrollment target is 870 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00201149, a NA study of Hypertension and Cardiovascular Diseases, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
870 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the effect of clinician counseling and cultural competence training on medication compliance and blood pressure (BP) control in patients with high BP.

Interventions

  • BEHAVIORAL Patient-centered Counseling

Study Locations (1)

Massachusetts

  • Boston University School of Medicine - Boston

Trial Details

FieldValue
Enrollment Target 870 participants
Start Date 2004-02
Est. Completion 2015-12
Phase NA
Boston Medical Center

253 total trials

What the finished NCT00201149 record still lists

NCT00201149 is an interventional study that assigns participants to a tested intervention. The registered 870 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (75% lower).

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Patient-centered Counseling is the first listed.

NCT00201149 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00201149 about?

NCT00201149 is a clinical study titled "Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence". The purpose of this study is to test the effect of clinician counseling and cultural competence training on medication compliance and blood pressure (BP) control in patients with high BP.

What is the current status of trial NCT00201149?

This trial is currently completed. It is a NA study. The enrollment target is 870 participants. The study started on 2004-02. Estimated completion is 2015-12.

What conditions does trial NCT00201149 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Heart Diseases.

What interventions are being tested in trial NCT00201149?

The interventions under investigation include: Patient-centered Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT00201149?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00201149 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00201149's enrollment target sits among peer trials

870 83rd of 470 higher than 388 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04097145 · 870 participants · NA

    Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

  • NCT06822790 · 869 participants · Phase 3

    Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

  • NCT06077760 · 868 participants · Phase 3

    A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

  • NCT04933552 · 867 participants

    Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00201149, the US trial registry maintained by the National Library of Medicine. NCT00201149 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.